PDF: Update on Drugs & Devices: May-June 2021

PDF Download: The update covers: Axatilimab IV injection – SNDX-6352 (Syndax Pharmaceuticals), Binimetinib tablets + encorafenib capsules – Mektovi® + Braftovi® (Pfizer Canada), Encapsulated cell therapy for Fabry disease – SIG-007 (Sigilon Therapeutics) and Oritavancin IV injection – Kimyrsa™ (Melinta Therapeutics).